4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-005616
CVP, Critical Care sold 75,600 shares at $88.94 ($6,724,234)
- CVP, Critical Care acquired 80,308 shares (option exercise)
- CVP, Critical Care gave up 3,530 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Szyman Catherine M. · CVP, Critical Care
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-07 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,708 | 32,060.78 | D | ||
| 2023-05-07 | Shares withheld for taxes : show line 2 in the form 10b5-1 | −2,154 | $88.74 | $191,146 | 29,906.78 | D |
| 2023-05-08 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −1,376 | $88.74 | $122,106 | 28,530.78 | D |
| 2023-05-09 | Exercise or conversion : show line 4 in the form 10b5-1 | +75,600 | $35.20 | $2,660,871 | 104,130.78 | D |
| 2023-05-09 | Sale : show line 5 in the form 10b5-1 | −75,600 | $88.94 | $6,724,234 | 28,530.78 | D |
| Open-market sales · 75,600 sh · avg $88.94 · $6,724,234 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-05-07 | Exercise or conversion : show line 6 in the form 10b5-1 Performance Rights | −4,708 | 2027-05-06 | 4,708 | 1,292 | D | |
| 2023-05-09 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −75,600 | $35.20 | 2023-05-11 | 75,600 | 0 | D |
Loading xslF345X04/doc4.xml…